Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma is a research paper published in Journal for ImmunoTherapy of Cancer (2020). On theSindex it has a DataRank of 0. It has been cited 55 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: R01CA16072
National Institute of Neurological Disorders and Stroke
Grant: R01NS032677
National Institutes of Health
Grant: 3R01NS032677-17S1
Genetically Engineered Viruses for Brain Tumor Therapy
NCI NIH HHS
Grant: R01 CA160762
FWCI
4.86
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals